Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
Condition: Breast Cancer Invasive Interventions: Drug: Pyrotinib; Drug: Trastuzumab; Drug: Pertuzumab; Drug: Nab-paclitaxel; Drug: EC chemotherapy; Drug: Physician's choice; Drug: T-DM1; Procedure: Surgery Sponsors: Shanghai Jiao Tong University School of Medicine; Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | HER2 | Herceptin | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Research